Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

RDNT vs UHS vs HCA vs THC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RDNT
RadNet, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.45B
5Y Perf.+237.4%
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.68B
5Y Perf.+61.7%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+301.5%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+792.1%

RDNT vs UHS vs HCA vs THC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RDNT logoRDNT
UHS logoUHS
HCA logoHCA
THC logoTHC
IndustryMedical - Diagnostics & ResearchMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$4.45B$10.68B$95.95B$17.01B
Revenue (TTM)$2.04B$17.76B$75.60B$21.45B
Net Income (TTM)$47M$1.52B$6.78B$1.70B
Gross Margin11.2%67.6%41.5%42.8%
Operating Margin3.0%11.5%15.8%16.1%
Forward P/E91.8x7.3x14.2x10.9x
Total Debt$1.86B$5.51B$50.20B$13.17B
Cash & Equiv.$767M$138M$1.04B$2.88B

RDNT vs UHS vs HCA vs THCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RDNT
UHS
HCA
THC
StockMay 20May 26Return
RadNet, Inc. (RDNT)100337.4+237.4%
Universal Health Se… (UHS)100161.7+61.7%
HCA Healthcare, Inc. (HCA)100401.5+301.5%
Tenet Healthcare Co… (THC)100892.1+792.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: RDNT vs UHS vs HCA vs THC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Tenet Healthcare Corporation is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. RDNT also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
RDNT
RadNet, Inc.
The Long-Run Compounder

RDNT is the clearest fit if your priority is long-term compounding.

  • 9.5% 10Y total return vs THC's 5.2%
  • 11.5% revenue growth vs THC's 3.1%
Best for: long-term compounding
UHS
Universal Health Services, Inc.
The Growth Play

UHS is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
  • Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
Best for: growth exposure and sleep-well-at-night
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Beta 0.29, yield 0.7%, current ratio 0.83x
  • 9.0% margin vs RDNT's 2.3%
  • Beta 0.29 vs RDNT's 1.43
Best for: income & stability and defensive
THC
Tenet Healthcare Corporation
The Value Pick

THC is the #2 pick in this set and the best alternative if valuation efficiency is your priority.

  • PEG 0.33 vs HCA's 0.67
  • Lower P/E (10.9x vs 14.2x), PEG 0.33 vs 0.67
  • +27.4% vs UHS's -8.2%
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthRDNT logoRDNT11.5% revenue growth vs THC's 3.1%
ValueTHC logoTHCLower P/E (10.9x vs 14.2x), PEG 0.33 vs 0.67
Quality / MarginsHCA logoHCA9.0% margin vs RDNT's 2.3%
Stability / SafetyHCA logoHCABeta 0.29 vs RDNT's 1.43
DividendsHCA logoHCA0.7% yield, 5-year raise streak, vs UHS's 0.5%, (2 stocks pay no dividend)
Momentum (1Y)THC logoTHC+27.4% vs UHS's -8.2%
Efficiency (ROA)HCA logoHCA11.3% ROA vs RDNT's 1.3%, ROIC 19.9% vs 2.0%

RDNT vs UHS vs HCA vs THC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RDNTRadNet, Inc.
FY 2025
Commercial Insurance1
58.8%$1.1B
Medicare1
24.8%$477M
Capitation Arrangements
6.5%$126M
Health Care, Other
3.4%$65M
Medicaid1
2.7%$52M
Workers' Compensation/Personal Injury1
2.3%$45M
Health Care, Management Service
1.4%$28M
UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B

RDNT vs UHS vs HCA vs THC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCALAGGINGRDNT

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 3 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 37.1x RDNT's $2.0B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to RDNT's 2.3%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
RevenueTrailing 12 months$2.0B$17.8B$75.6B$21.5B
EBITDAEarnings before interest/tax$214M$2.7B$15.5B$4.3B
Net IncomeAfter-tax profit$47M$1.5B$6.8B$1.7B
Free Cash FlowCash after capex-$178M$894M$7.7B$3.3B
Gross MarginGross profit ÷ Revenue+11.2%+67.6%+41.5%+42.8%
Operating MarginEBIT ÷ Revenue+3.0%+11.5%+15.8%+16.1%
Net MarginNet income ÷ Revenue+2.3%+8.6%+9.0%+7.9%
FCF MarginFCF ÷ Revenue-8.7%+5.0%+10.2%+15.6%
Rev. Growth (YoY)Latest quarter vs prior year+14.8%+9.6%+6.7%+2.8%
EPS Growth (YoY)Latest quarter vs prior year-114.1%+17.7%+44.6%+87.6%
THC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

UHS leads this category, winning 4 of 7 comparable metrics.

At 7.4x trailing earnings, UHS trades at a 51% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Market CapShares × price$4.5B$10.7B$95.9B$17.0B
Enterprise ValueMkt cap + debt − cash$5.5B$16.0B$145.1B$27.3B
Trailing P/EPrice ÷ TTM EPS-230.00x7.38x15.12x12.53x
Forward P/EPrice ÷ next-FY EPS est.91.75x7.30x14.19x10.94x
PEG RatioP/E ÷ EPS growth rate0.46x0.72x0.38x
EV / EBITDAEnterprise value multiple25.88x6.14x9.37x6.34x
Price / SalesMarket cap ÷ Revenue2.18x0.61x1.27x0.80x
Price / BookPrice ÷ Book value/share3.19x1.48x1.97x
Price / FCFMarket cap ÷ FCF52.01x12.57x12.47x6.72x
UHS leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

HCA leads this category, winning 4 of 9 comparable metrics.

UHS delivers a 20.7% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $4 for RDNT. UHS carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs RDNT's 5/9, reflecting strong financial health.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
ROE (TTM)Return on equity+3.8%+20.7%+19.6%
ROA (TTM)Return on assets+1.3%+9.8%+11.3%+5.7%
ROICReturn on invested capital+2.0%+12.3%+19.9%+13.2%
ROCEReturn on capital employed+2.1%+16.0%+27.0%+13.8%
Piotroski ScoreFundamental quality 0–95677
Debt / EquityFinancial leverage1.37x0.74x1.47x
Net DebtTotal debt minus cash$1.1B$5.4B$49.2B$10.3B
Cash & Equiv.Liquid assets$767M$138M$1.0B$2.9B
Total DebtShort + long-term debt$1.9B$5.5B$50.2B$13.2B
Interest CoverageEBIT ÷ Interest expense1.46x10.92x5.37x4.28x
HCA leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $11,248 for UHS. Over the past 12 months, THC leads with a +27.4% total return vs UHS's -8.2%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs UHS's 6.5% — a key indicator of consistent wealth creation.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
YTD ReturnYear-to-date-19.0%-22.3%-8.6%-2.7%
1-Year ReturnPast 12 months+4.6%-8.2%+19.7%+27.4%
3-Year ReturnCumulative with dividends+100.0%+20.8%+57.4%+178.5%
5-Year ReturnCumulative with dividends+147.1%+12.5%+109.7%+190.4%
10-Year ReturnCumulative with dividends+947.4%+30.8%+450.5%+523.4%
CAGR (3Y)Annualised 3-year return+26.0%+6.5%+16.3%+40.7%
THC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than RDNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 78.5% from its 52-week high vs RDNT's 67.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Beta (5Y)Sensitivity to S&P 5001.43x0.60x0.29x0.71x
52-Week HighHighest price in past year$85.84$246.33$556.52$247.21
52-Week LowLowest price in past year$50.76$152.33$330.00$146.60
% of 52W HighCurrent price vs 52-week peak+67.0%+69.2%+77.1%+78.5%
RSI (14)Momentum oscillator 0–10051.339.730.852.9
Avg Volume (50D)Average daily shares traded822K793K1000K1.2M
Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: RDNT as "Buy", UHS as "Hold", HCA as "Buy", THC as "Buy". Consensus price targets imply 60.0% upside for RDNT (target: $92) vs 22.9% for HCA (target: $527). For income investors, HCA offers the higher dividend yield at 0.69% vs UHS's 0.47%.

MetricRDNT logoRDNTRadNet, Inc.UHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuy
Price TargetConsensus 12-month target$92.00$231.50$527.45$268.00
# AnalystsCovering analysts11434632
Dividend YieldAnnual dividend ÷ price+0.5%+0.7%
Dividend StreakConsecutive years of raises0150
Dividend / ShareAnnual DPS$0.80$2.94
Buyback YieldShare repurchases ÷ mkt cap0.0%+9.1%+10.5%+8.4%
HCA leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

THC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). HCA leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.

Best OverallHCA Healthcare, Inc. (HCA)Leads 2 of 6 categories
Loading custom metrics...

RDNT vs UHS vs HCA vs THC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is RDNT or UHS or HCA or THC a better buy right now?

For growth investors, RadNet, Inc.

(RDNT) is the stronger pick with 11. 5% revenue growth year-over-year, versus 3. 1% for Tenet Healthcare Corporation (THC). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 4x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RDNT or UHS or HCA or THC?

On trailing P/E, Universal Health Services, Inc.

(UHS) is the cheapest at 7. 4x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — RDNT or UHS or HCA or THC?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to +12. 5% for Universal Health Services, Inc. (UHS). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus UHS's +30. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RDNT or UHS or HCA or THC?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 398% more volatile than HCA relative to the S&P 500. On balance sheet safety, Universal Health Services, Inc. (UHS) carries a lower debt/equity ratio of 74% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — RDNT or UHS or HCA or THC?

By revenue growth (latest reported year), RadNet, Inc.

(RDNT) is pulling ahead at 11. 5% versus 3. 1% for Tenet Healthcare Corporation (THC). On earnings-per-share growth, the picture is similar: Universal Health Services, Inc. grew EPS 37. 3% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RDNT or UHS or HCA or THC?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 2. 3% for RadNet, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus 3. 0% for RDNT. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RDNT or UHS or HCA or THC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Universal Health Services, Inc. (UHS) trades at 7. 3x forward P/E versus 91. 8x for RadNet, Inc. — 84. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RDNT: 60. 0% to $92. 00.

08

Which pays a better dividend — RDNT or UHS or HCA or THC?

In this comparison, HCA (0.

7% yield), UHS (0. 5% yield) pay a dividend. RDNT, THC do not pay a meaningful dividend and should not be held primarily for income.

09

Is RDNT or UHS or HCA or THC better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Both have compounded well over 10 years (HCA: +450. 5%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RDNT and UHS and HCA and THC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RDNT is a small-cap quality compounder stock; UHS is a mid-cap deep-value stock; HCA is a mid-cap deep-value stock; THC is a mid-cap deep-value stock. HCA pays a dividend while RDNT, UHS, THC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

RDNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RDNT and UHS and HCA and THC on the metrics below

Revenue Growth>
%
(RDNT: 14.8% · UHS: 9.6%)
Net Margin>
%
(RDNT: 2.3% · UHS: 8.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.